Oxford vaccine is a winner, virus variant seems manageable

Here are Monday morning reports on the efficacy and handy nature of the AstraZeneca vaccine created in collaboration with Oxford University. It looks good. Then, the CBC interviews an epidemiologist who suggests there’s nothing about the C-19 variant that should scare us more than the original.